SPHK1 and carcinoma of esophagus: In 2011, Pan et al. [114] identified SphK1 as a key mediator of aggressive, invasive, oesophageal cancer cells and suggested that blocking this pathway may be a way forward to disruption of the metastatic phenotype and more efficacious treatment.